http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-527396-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-72
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-72
filingDate 1939-04-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1940-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-527396-A
titleOfInvention Process for the manufacture of condensation products from trimethyl-hydroquinone andalkylene halides
abstract 527,396. Vitamins. HOFFMAN-LA ROCHE & CO., AKT.-GES., F. April 11, 1939, No. 10973. Convention date, April 12, 1938. Samples furnished. [Class 2 (iii)] Compounds corresponding to the general formulae are prepared by condensing trimethylhydroquinone with alkylene halides, other than phytyl halides, of the general formula X CH 2 - CH =CR<SP>1</SP>R<SP>11</SP>, in which X stands for halogen, and R<SP>1</SP> and R<SP>11</SP> for hydrogen or alkyl or alkyline groups in an indifferent solvent in the presence of acid condensing agents. If R<SP>1</SP> and R<SP>11</SP> represent hydrogen, a compound of formula I is obtained. If R<SP>1</SP> and R<SP>11</SP> represent alkyl or alkylene groups, compounds of formula II are obtained. Zinc chloride or aluminium chloride may be used as condensing agents. The products are useful medicinally. In the examples (1) trimethyl-hydroquinone condensed with geramyl bromide in the presence of anhydrous zinc chloride yields a compound of the formula It is purified by transformation into its allophanate ; (2) trimethyl-hydroquinone is condensed with alkyl bromide in the presence of anhydrous zinc chloride yielding 2.4.6.7.- tetramethyl-5-oxy-cumarane of the formula The samples furnished under Sect. 2 (5) of the Acts comprise (1) the allophanate of the compound from trimethylhydroquinone and geramyl bromide, obtained according to example 1 , (2) 2.4.6.7-tetramethyl-5-oxy-cumarane obtained in accordance with example (2) ; (3) 2.5.7.8-tetramethyl-6-oxy-chromane prepared by condensing crotyl bromide with trimethylhydroquinone.
priorityDate 1938-04-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID259
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449957047
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9543250
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546766
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420660139
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419589861
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID122414
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3007855
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10931625
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24012
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410496548
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559212

Total number of triples: 24.